$ICLK
iClick Interactive Asia Group Ltd Stock $iclk

$iclk Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000110465923059102 Filed on May 11, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$42.60M	$169.1M	$76.32M
YoY Change	-44.18%	-45.05%	-3.01%
Cost Of Revenue	$81.18M	$173.2M	$52.77M
YoY Change	53.83%	-20.74%	-4.79%
Gross Profit	-$38.58M	-$4.132M	$23.55M
YoY Change	-263.82%	-104.63%	1.25%
Gross Profit Margin	-90.56%	-2.44%	30.86%
Selling, General & Admin	$29.92M	$96.28M	$25.42M
YoY Change	17.7%	4.82%	12.58%
% of Gross Profit			107.94%
Research & Development	$2.430M	$9.216M	$3.197M
YoY Change	-23.99%	-1.7%	70.05%
% of Gross Profit			13.58%
Depreciation & Amortization		$842.0K
YoY Change		-78.33%
% of Gross Profit
Operating Expenses	$32.34M	$190.0M	$28.62M
YoY Change	13.01%	86.23%	17.05%
Operating Profit	-$70.92M	-$194.2M	-$5.068M
YoY Change	1299.37%	1406.47%	325.88%
Interest Expense	$100.0K	$2.057M	-$579.0K
YoY Change	-117.27%	-169.52%	-13.58%
% of Operating Profit
Other Income/Expense, Net	-$13.18M	-$254.0K	-$752.0K
YoY Change	1652.66%	-104.28%	-126.76%
Pretax Income	-$139.9M	-$213.9M	-$6.399M
YoY Change	2085.81%	1433.22%	-773.58%
Income Tax	-$11.54M	-$11.18M	$671.0K
% Of Pretax Income
Net Earnings	-$128.2M	-$200.9M	-$5.986M
YoY Change	2042.17%	1373.66%	-564.03%
Net Earnings / Revenue	-301.01%	-118.8%	-7.84%
Basic Earnings Per Share		-$3.98
Diluted Earnings Per Share	-$2.32	-$3.98	-$118.2K
COMMON SHARES
Basic Shares Outstanding		50.42M
Diluted Shares Outstanding		50.42M

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$89.80M	$89.80M	$60.34M
YoY Change	48.82%	48.82%	-20.6%
Cash & Equivalents	$82.75M	$89.80M	$49.21M
Short-Term Investments	$0.00	$0.00	$11.13M
Other Short-Term Assets	$8.047M	$45.20M	$98.09M
YoY Change	-91.8%	-46.52%	7.79%
Inventory
Prepaid Expenses	$2.917M		$7.520M
Receivables	$64.56M	$64.60M	$187.3M
Other Receivables	$2.900M	$5.100M	$5.575M
Total Short-Term Assets	$204.7M	$204.7M	$351.3M
YoY Change	-41.74%	-41.73%	9.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$241.0K	$1.500M	$5.765M
YoY Change	-95.82%	-73.98%	28.11%
Goodwill			$81.67M
YoY Change			9.75%
Intangibles
YoY Change
Long-Term Investments	$279.0K	$6.200M	$12.47M
YoY Change	-97.76%	-50.27%	37.01%
Other Assets	$7.629M	$8.300M	$2.848M
YoY Change	167.87%	191.43%	-35.27%
Total Long-Term Assets	$17.12M	$17.10M	$156.5M
YoY Change	-89.06%	-89.07%	5.08%
TOTAL ASSETS
Total Short-Term Assets	$204.7M	$204.7M	$351.3M
Total Long-Term Assets	$17.12M	$17.10M	$156.5M
Total Assets	$221.8M	$221.8M	$507.7M
YoY Change	-56.32%	-56.32%	8.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.73M	$41.70M	$66.59M
YoY Change	-37.33%	-37.38%	54.49%
Accrued Expenses	$32.70M	$30.80M	$31.88M
YoY Change	2.59%	24.0%	1.84%
Deferred Revenue	$16.98M		$22.80M
YoY Change	-25.55%		-19.14%
Short-Term Debt	$44.30M	$44.30M	$75.53M
YoY Change	-41.35%	-41.35%	34.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$137.7M	$137.7M	$200.8M
YoY Change	-31.43%	-31.44%	23.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.071M	$3.500M	$1.922M
YoY Change	7.75%	82.1%	-86.27%
Total Long-Term Liabilities	$4.777M	$3.500M	$1.922M
YoY Change	148.54%	82.1%	-86.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$137.7M	$137.7M	$200.8M
Total Long-Term Liabilities	$4.777M	$3.500M	$1.922M
Total Liabilities	$142.5M	$146.9M	$223.4M
YoY Change	-36.21%	-34.24%	12.82%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$529.5M		$525.5M
YoY Change	0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$74.93M	$74.90M	$284.4M
YoY Change
Total Liabilities & Shareholders Equity	$221.8M	$221.8M	$507.7M
YoY Change	-56.32%	-56.32%	8.01%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$128.2M	-$200.9M	-$5.986M
YoY Change	2042.17%	1373.66%	-564.03%
Depreciation, Depletion And Amortization		$842.0K
YoY Change		-78.33%
Cash From Operating Activities		$71.10M
YoY Change		-461.43%
INVESTING ACTIVITIES
Capital Expenditures		$506.0K
YoY Change		-131.84%
Acquisitions		$7.742M
YoY Change		-22.63%
Other Investing Activities		-$3.470M
YoY Change		-83.32%
Cash From Investing Activities		-$3.977M
YoY Change		-82.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$7.574M
YoY Change		8.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-37.29M
YoY Change		-250.71%
NET CHANGE
Cash From Operating Activities		71.10M
Cash From Investing Activities		-3.977M
Cash From Financing Activities		-37.29M
Net Change In Cash		29.84M
YoY Change		-272.27%
FREE CASH FLOW
Cash From Operating Activities		$71.10M
Capital Expenditures		$506.0K
Free Cash Flow		$70.60M
YoY Change		-490.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	000000
CY2021	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P3M
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2021Q4	iclk	Number Of Common Stock Per Ads NumberOfCommonStockPerAds	1.5
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	824000
CY2022	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	1478000
CY2020	us-gaap	Interest Expense InterestExpense	2650000
CY2021	us-gaap	Interest Expense InterestExpense	4089000
CY2022	us-gaap	Interest Expense InterestExpense	2057000
CY2020	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	5852000
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	2203000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6587000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3999000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	265000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	661000
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39368436
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50420225
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001697818
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48187235
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38313
CY2022	dei	Entity Registrant Name EntityRegistrantName	iClick Interactive Asia Group Limited
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	15/F
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Prosperity Millennia Plaza
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	663 King’s Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Quarry Bay
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	Security12b Title Security12bTitle	American Depositary Shares, one representing five Class A ordinary shares, par value US$0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	ICLK
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	1389
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers
CY2022	dei	Auditor Location AuditorLocation	Hong Kong
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41443000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82754000
CY2021Q4	iclk	Time Deposits In Bank TimeDepositsInBank	11128000
CY2022Q4	iclk	Time Deposits In Bank TimeDepositsInBank	10000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	36146000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	22543000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	7771000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	7011000
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	276000
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	312000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22786000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37215000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	187261000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64556000
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	5575000
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	2933000
CY2021Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	36709000
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	16494000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	289000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24957000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8047000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	351266000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	204660000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1185000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	720000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1931000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	241000
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	354000
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	279000
CY2021Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	12114000
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	5970000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53713000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	991000
CY2021Q4	us-gaap	Goodwill Goodwill	81674000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3834000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1292000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4043000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1663000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7629000
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	156468000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	17122000
CY2021Q4	us-gaap	Assets Assets	507734000
CY2022Q4	us-gaap	Assets Assets	221782000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	66587000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41728000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22802000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16975000
CY2021Q4	iclk	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	29735000
CY2022Q4	iclk	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	30539000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2141000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2151000
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	75530000
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	44283000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4050000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2040000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	200845000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	137716000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1463000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1380000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13378000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1326000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	459000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2071000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15300000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4777000
CY2021Q4	us-gaap	Liabilities Liabilities	216145000
CY2022Q4	us-gaap	Liabilities Liabilities	142493000
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2323802
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5843335
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20908000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	28457000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	525508000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	529455000
CY2021Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	81000
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	81000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	860000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4086000
CY2021Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	-221237000
CY2022Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	-422112000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	284352000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74930000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	7237000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4359000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	291589000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	79289000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	507734000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	221782000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254745000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169080000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181482000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	218549000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	173212000
CY2020	us-gaap	Gross Profit GrossProfit	73263000
CY2021	us-gaap	Gross Profit GrossProfit	89153000
CY2022	us-gaap	Gross Profit GrossProfit	-4132000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5349000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9527000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9216000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38028000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52872000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44613000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31648000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39643000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51668000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4403000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	80137000
CY2020	us-gaap	Operating Expenses OperatingExpenses	75025000
CY2021	us-gaap	Operating Expenses OperatingExpenses	102042000
CY2022	us-gaap	Operating Expenses OperatingExpenses	190037000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-1762000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-12889000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-194169000
CY2020	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	1297000
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-19165000
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-11466000
CY2020	iclk	Fair Value Loss Gain On Convertible Notes FairValueLossGainOnConvertibleNotes	4433000
CY2020	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-13162000
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-13951000
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-213913000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-111000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-107000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-75000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1633000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2540000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11182000
CY2020	us-gaap	Profit Loss ProfitLoss	-14906000
CY2021	us-gaap	Profit Loss ProfitLoss	-16598000
CY2022	us-gaap	Profit Loss ProfitLoss	-202806000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2288000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2967000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1931000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12618000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-13631000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-200875000
CY2020	us-gaap	Profit Loss ProfitLoss	-14906000
CY2021	us-gaap	Profit Loss ProfitLoss	-16598000
CY2022	us-gaap	Profit Loss ProfitLoss	-202806000
CY2020	us-gaap	Translation Adjustment Functional To Reporting Currency Gain Loss Reclassified To Earnings Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax	0
CY2021	us-gaap	Translation Adjustment Functional To Reporting Currency Gain Loss Reclassified To Earnings Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax	0
CY2022	us-gaap	Translation Adjustment Functional To Reporting Currency Gain Loss Reclassified To Earnings Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax	0
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5274000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3484000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5060000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9632000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13114000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-207866000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2015000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2823000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2045000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7617000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10291000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-205821000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.98
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.98
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39368436
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48187235
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50420225
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39368436
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48187235
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50420225
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114556000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1305000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6249000
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5677000
CY2020	iclk	Stock Issued During Period Value Purchase Of Interests In Subsidiaries From Non Controlling Interests StockIssuedDuringPeriodValuePurchaseOfInterestsInSubsidiariesFromNonControllingInterests	-7003000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	71917000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	68895000
CY2020	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	42377000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	73000
CY2020	us-gaap	Profit Loss ProfitLoss	-14906000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5274000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	279088000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	279088000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	661000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11969000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10687000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	18540000
CY2021	iclk	Stock Issued During Period Value Upon Settlement For Contingent Consideration Payable StockIssuedDuringPeriodValueUponSettlementForContingentConsiderationPayable	2060000
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	3072000
CY2021	us-gaap	Profit Loss ProfitLoss	-16598000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3484000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	291589000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	291589000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	68000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3794000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7574000
CY2022	iclk	Stock Issued During Period Value Purchase Of Interests In Subsidiaries From Non Controlling Interests StockIssuedDuringPeriodValuePurchaseOfInterestsInSubsidiariesFromNonControllingInterests	-722000
CY2022	us-gaap	Profit Loss ProfitLoss	-202806000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5060000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	79289000
CY2020	us-gaap	Profit Loss ProfitLoss	-14906000
CY2021	us-gaap	Profit Loss ProfitLoss	-16598000
CY2022	us-gaap	Profit Loss ProfitLoss	-202806000
CY2020	us-gaap	Depreciation Depreciation	381000
CY2021	us-gaap	Depreciation Depreciation	648000
CY2022	us-gaap	Depreciation Depreciation	842000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4189000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3238000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2990000
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1930000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2785000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2650000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	16000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	40000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	12424000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	18542000
CY2020	iclk	Accounts Receivable Written Off AccountsReceivableWrittenOff	2621000
CY2021	iclk	Accounts Receivable Written Off AccountsReceivableWrittenOff	1669000
CY2022	iclk	Accounts Receivable Written Off AccountsReceivableWrittenOff	1978000
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	289000
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3661000
CY2022	iclk	Other Receivable Written Off OtherReceivableWrittenOff	7566000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1530000
CY2020	iclk	Other Share Based Compensation Expenses OtherShareBasedCompensationExpenses	6249000
CY2021	iclk	Other Share Based Compensation Expenses OtherShareBasedCompensationExpenses	11969000
CY2022	iclk	Other Share Based Compensation Expenses OtherShareBasedCompensationExpenses	3794000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	11466000
CY2020	iclk	Fair Value Gain Loss On Convertible Notes FairValueGainLossOnConvertibleNotes	-4433000
CY2020	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	1404000
CY2021	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	-316000
CY2022	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	-2368000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	80137000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	49778000
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	4038000
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	10805000
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	1206000
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2365000
CY2021	iclk	Fair Value Changes On Contingent Consideration Payables FairValueChangesOnContingentConsiderationPayables	-418000
CY2022	iclk	Fair Value Changes On Contingent Consideration Payables FairValueChangesOnContingentConsiderationPayables	8396000
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1151000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-905000
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-11557000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-111000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-107000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-75000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1996000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	58615000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-104006000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1426000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3333000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-912000
CY2020	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	4987000
CY2021	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-5626000
CY2022	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-2642000
CY2020	us-gaap	Increase Decrease In Prepaid Advertising IncreaseDecreaseInPrepaidAdvertising	8383000
CY2021	us-gaap	Increase Decrease In Prepaid Advertising IncreaseDecreaseInPrepaidAdvertising	1463000
CY2022	us-gaap	Increase Decrease In Prepaid Advertising IncreaseDecreaseInPrepaidAdvertising	-17515000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23345000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23447000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24859000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3392000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1504000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	68000
CY2020	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	180511000
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	248784000
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	180006000
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	165131000
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	231025000
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	209789000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5323000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6935000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-121000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-80000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1839000
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	55000
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-7000
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	319000
CY2020	iclk	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2173000
CY2021	iclk	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2781000
CY2022	iclk	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-2776000
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	63000
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	58000
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	36000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19633000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19673000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71104000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	556000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1386000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	506000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	575000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	203000
CY2020	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	22267000
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-15633000
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	99000
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	412000
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	7129000
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	4108000
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	6500000
CY2020	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	1901000
CY2021	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	394000
CY2020	iclk	Payments For Proceeds From Time Deposits PaymentsForProceedsFromTimeDeposits	-321000
CY2021	iclk	Payments For Proceeds From Time Deposits PaymentsForProceedsFromTimeDeposits	11039000
CY2022	iclk	Payments For Proceeds From Time Deposits PaymentsForProceedsFromTimeDeposits	-11118000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-6226000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10007000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7742000
CY2022	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	722000
CY2020	iclk	Payments Proceeds From To Acquire Loans Receivable PaymentsProceedsFromToAcquireLoansReceivable	1400000
CY2021	iclk	Payments Proceeds From To Acquire Loans Receivable PaymentsProceedsFromToAcquireLoansReceivable	17303000
CY2021	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	6400000
CY2022	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	434000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	17000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	40000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27693000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22390000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3977000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1305000
CY2020	iclk	Proceeds From Issuance Of Convertible Notes Net Of Transaction Expenses ProceedsFromIssuanceOfConvertibleNotesNetOfTransactionExpenses	19184000
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	15196000
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	73000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5677000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10687000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7574000
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	71917000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17010000
CY2021Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	12114000
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7003000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	79983000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24743000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-37289000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	32657000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17320000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	29838000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60706000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77589000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1014000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	532000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2130000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77589000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105297000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52232000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41443000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82754000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42145000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	36146000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	22543000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77589000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105297000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2545000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3922000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2114000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2960000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3677000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1949000
CY2020	iclk	Fair Value Gain Loss On Convertible Notes FairValueGainLossOnConvertibleNotes	-4433000
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-11466000
CY2020	iclk	Issuance Of Ordinary Shares Value Upon Conversion Of Convertible Notes IssuanceOfOrdinarySharesValueUponConversionOfConvertibleNotes	68895000
CY2020	iclk	Issuance Of Ordinary Shares Value Upon Acquisition IssuanceOfOrdinarySharesValueUponAcquisition	42377000
CY2020	iclk	Issuance Of Convertible Notes Upon Exercise Of Call Option IssuanceOfConvertibleNotesUponExerciseOfCallOption	11466000
CY2022	iclk	Issuance Of Ordinary Shares Upon Acquisition Of Interest In Subsidiary From Non Controlling Interests IssuanceOfOrdinarySharesUponAcquisitionOfInterestInSubsidiaryFromNonControllingInterests	1577000
CY2021	iclk	Issuance Of Ordinary Shares Upon Settlement For Contingent Consideration Payable IssuanceOfOrdinarySharesUponSettlementForContingentConsiderationPayable	2060000
CY2021	iclk	Transfer Of Prepayments For Long Term Investments To Other Long Term Investments TransferOfPrepaymentsForLongTermInvestmentsToOtherLongTermInvestments	7023000
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	5970000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	12295000
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	726000
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	7000
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	37000
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1275000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">(b)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">Use of estimates</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 36pt;">The preparation of the Group’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from such estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 36pt;">The Group believes that revenue recognition in determining whether the Company is the principal or an agent to the arrangements with merchants, impairment assessment of goodwill and long-lived assets, fair value determination related to the accounting for business combinations, impairment assessment of investments in equity securities without readily determinable fair value, determination of share-based compensation and valuation of convertible notes reflect more significant judgments and estimates used in the preparation of its consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 36pt;">Management bases the estimates on historical experience and on various other assumptions as discussed elsewhere to the consolidated financial statements that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could materially differ from these estimates.</p>
CY2020	iclk	Impairments Of Assets ImpairmentsOfAssets	0
CY2021	iclk	Impairments Of Assets ImpairmentsOfAssets	0
CY2022	iclk	Impairments Of Assets ImpairmentsOfAssets	0
CY2022	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	11458000
CY2021Q4	iclk	Credit Loss Provision For Accounts Receivable And Loans And Interest Receivable CreditLossProvisionForAccountsReceivableAndLoansAndInterestReceivable	23075000
CY2022Q4	iclk	Credit Loss Provision For Accounts Receivable And Loans And Interest Receivable CreditLossProvisionForAccountsReceivableAndLoansAndInterestReceivable	41258000
CY2021Q4	iclk	Provision For Credit Losses Individually Assessed Receivables ProvisionForCreditLossesIndividuallyAssessedReceivables	13243000
CY2022Q4	iclk	Provision For Credit Losses Individually Assessed Receivables ProvisionForCreditLossesIndividuallyAssessedReceivables	20233000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	7771000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	7011000
CY2021Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	12114000
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	5970000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	222173000
CY2020	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	4038000
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	10805000
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	277445000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	157622000
CY2021	iclk	Contract With Customer Liability Revenue Recognized For Beginning Balance ContractWithCustomerLiabilityRevenueRecognizedForBeginningBalance	18795000
CY2022	iclk	Contract With Customer Liability Revenue Recognized For Beginning Balance ContractWithCustomerLiabilityRevenueRecognizedForBeginningBalance	13108000
CY2022	us-gaap	Revenue Practical Expedient Remaining Performance Obligation RevenuePracticalExpedientRemainingPerformanceObligation	true
CY2022	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	false
CY2022	iclk	Impairment Of Long Lived Assets ImpairmentOfLongLivedAssets	53349000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	49778000
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1206000
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2365000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	53349000
CY2022	us-gaap	Revenue Practical Expedient Financing Component RevenuePracticalExpedientFinancingComponent	false
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7520000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2917000
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-11466000
CY2021Q4	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2022Q4	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254745000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169080000
CY2020	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	32572000
CY2021	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	30257000
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	156000
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	111000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	8658000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	10458000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6769000
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022	iclk	Appropriation Of Net Income To Statutory Reserve Required Percentage AppropriationOfNetIncomeToStatutoryReserveRequiredPercentage	0.10
CY2022	iclk	Reserve Level Threshold For Mandatory Transfer Percentage ReserveLevelThresholdForMandatoryTransferPercentage	0.50
CY2021	iclk	Intercompany Online Advertising And Saas Service Revenues From Variable Interest Entity IntercompanyOnlineAdvertisingAndSaasServiceRevenuesFromVariableInterestEntity	49000
CY2022	iclk	Intercompany Online Advertising And Saas Service Revenues From Variable Interest Entity IntercompanyOnlineAdvertisingAndSaasServiceRevenuesFromVariableInterestEntity	285000
CY2020Q4	iclk	Management Fees From Variable Interest Entity ManagementFeesFromVariableInterestEntity	0
CY2021Q4	iclk	Management Fees From Variable Interest Entity ManagementFeesFromVariableInterestEntity	0
CY2022Q4	iclk	Management Fees From Variable Interest Entity ManagementFeesFromVariableInterestEntity	0
CY2020	us-gaap	Dividends Dividends	0
CY2021	us-gaap	Dividends Dividends	0
CY2022	us-gaap	Dividends Dividends	0
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020	iclk	Intercompany Online Advertising Service Revenues Variable Interest Entity IntercompanyOnlineAdvertisingServiceRevenuesVariableInterestEntity	4761000
CY2021	iclk	Intercompany Online Advertising Service Revenues Variable Interest Entity IntercompanyOnlineAdvertisingServiceRevenuesVariableInterestEntity	911000
CY2022	iclk	Intercompany Online Advertising Service Revenues Variable Interest Entity IntercompanyOnlineAdvertisingServiceRevenuesVariableInterestEntity	291000
CY2021	iclk	Intercompany Marketing Service Revenue Variable Interest Entity IntercompanyMarketingServiceRevenueVariableInterestEntity	117000
CY2022	iclk	Intercompany Marketing Service Revenue Variable Interest Entity IntercompanyMarketingServiceRevenueVariableInterestEntity	310000
CY2020	iclk	Intercompany Online Advertising And Saas Service Revenues From Variable Interest Entity IntercompanyOnlineAdvertisingAndSaasServiceRevenuesFromVariableInterestEntity	996000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4507000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	4507000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0
CY2021	iclk	Impairment On Long Term Investments ImpairmentOnLongTermInvestments	4038000
CY2022	iclk	Impairment On Long Term Investments ImpairmentOnLongTermInvestments	10805000
CY2022	iclk	Fair Value Of Investments In Equity Securities FairValueOfInvestmentsInEquitySecurities	1
CY2021	iclk	Fair Value Of Investments In Equity Securities FairValueOfInvestmentsInEquitySecurities	3
CY2022Q4	us-gaap	Equity Securities Fv Ni Measurement Input EquitySecuritiesFvNiMeasurementInput	0.20
CY2021Q4	us-gaap	Equity Securities Fv Ni Measurement Input EquitySecuritiesFvNiMeasurementInput	0.20
CY2022	iclk	Price To Sales Multiples PriceToSalesMultiples	7.6
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	100000000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	12903000
CY2022Q4	iclk	Time Deposits In Bank TimeDepositsInBank	10000
CY2021Q4	iclk	Time Deposits In Bank TimeDepositsInBank	11128000
CY2022	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P5M
CY2021Q4	iclk	Cash Cash Equivalents And Time Deposits CashCashEquivalentsAndTimeDeposits	52571000
CY2022Q4	iclk	Cash Cash Equivalents And Time Deposits CashCashEquivalentsAndTimeDeposits	82764000
CY2022	iclk	Fixed Interest Weighted Average Rate FixedInterestWeightedAverageRate	0.0234
CY2021	iclk	Fixed Interest Weighted Average Rate FixedInterestWeightedAverageRate	0.0033
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	460000
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	354000
CY2021	iclk	Accumulated Income Loss From Equity Method Investments AccumulatedIncomeLossFromEquityMethodInvestments	107000
CY2022	iclk	Accumulated Income Loss From Equity Method Investments AccumulatedIncomeLossFromEquityMethodInvestments	75000
CY2021	iclk	Equity Method Investment Exchange Difference EquityMethodInvestmentExchangeDifference	1000
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	354000
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	279000
CY2021	iclk	Accumulated Income Loss From Equity Method Investments AccumulatedIncomeLossFromEquityMethodInvestments	107000
CY2022	iclk	Accumulated Income Loss From Equity Method Investments AccumulatedIncomeLossFromEquityMethodInvestments	75000
CY2021Q4	iclk	Due From Equity Method Investment DueFromEquityMethodInvestment	276000
CY2022Q4	iclk	Due From Equity Method Investment DueFromEquityMethodInvestment	312000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3000000
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	16152000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	13775000
CY2021Q4	iclk	Other Long Term Investments Gross OtherLongTermInvestmentsGross	16152000
CY2022Q4	iclk	Other Long Term Investments Gross OtherLongTermInvestmentsGross	16775000
CY2021	iclk	Other Long Term Investments Impairment OtherLongTermInvestmentsImpairment	4038000
CY2022	iclk	Other Long Term Investments Impairment OtherLongTermInvestmentsImpairment	10805000
CY2020Q4	iclk	Other Long Term Investments And Prepayments For Long Term Investments OtherLongTermInvestmentsAndPrepaymentsForLongTermInvestments	11575000
CY2021Q4	iclk	Other Long Term Investments And Prepayments For Long Term Investments OtherLongTermInvestmentsAndPrepaymentsForLongTermInvestments	12114000
CY2021	iclk	Other Long Term Investments Made And Transferred From Prepayments OtherLongTermInvestmentsMadeAndTransferredFromPrepayments	4502000
CY2022	iclk	Other Long Term Investments Made And Transferred From Prepayments OtherLongTermInvestmentsMadeAndTransferredFromPrepayments	3500000
CY2022	iclk	Other Long Term Investments Transfer To Short Term OtherLongTermInvestmentsTransferToShortTerm	-1510000
CY2021	iclk	Other Long Term Investments Impairment OtherLongTermInvestmentsImpairment	4038000
CY2022	iclk	Other Long Term Investments Impairment OtherLongTermInvestmentsImpairment	10805000
CY2021	iclk	Other Long Term Investments Exchange Differences OtherLongTermInvestmentsExchangeDifferences	75000
CY2022	iclk	Other Long Term Investments Exchange Differences OtherLongTermInvestmentsExchangeDifferences	-329000
CY2021Q4	iclk	Other Long Term Investments And Prepayments For Long Term Investments OtherLongTermInvestmentsAndPrepaymentsForLongTermInvestments	12114000
CY2022Q4	iclk	Other Long Term Investments And Prepayments For Long Term Investments OtherLongTermInvestmentsAndPrepaymentsForLongTermInvestments	2970000
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	4038000
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	10805000
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	210047000
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	101771000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22786000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37215000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	187261000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64556000
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2609000
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1928000
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1411000
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1251000
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1028000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24957000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8047000
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	302000
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	522000
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	6073000
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1361000
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1034000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1663000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7629000
CY2021	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	due on demand or within one year from the end of the reporting period.
CY2022	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	beyond one year from the end of the reporting period.
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8917000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9157000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6918000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7512000
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1206000
CY2021Q4	iclk	Property Plant And Equipment Foreign Currency Translation Adjustment PropertyPlantAndEquipmentForeignCurrencyTranslationAdjustment	68000
CY2022Q4	iclk	Property Plant And Equipment Foreign Currency Translation Adjustment PropertyPlantAndEquipmentForeignCurrencyTranslationAdjustment	198000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1931000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	241000
CY2020	us-gaap	Depreciation Depreciation	381000
CY2021	us-gaap	Depreciation Depreciation	648000
CY2022	us-gaap	Depreciation Depreciation	842000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1518000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	894000
CY2020	us-gaap	Lease Cost LeaseCost	3067000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	80984000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	81088000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27336000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	30326000
CY2022Q4	iclk	Finite Lived Intangible Assets Accumulated Impairment Losses FiniteLivedIntangibleAssetsAccumulatedImpairmentLosses	-49778000
CY2021	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-65000
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-7000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53713000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	991000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4189000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3238000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2990000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	563000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	425000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	991000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	2155000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2862000
CY2020Q4	us-gaap	Goodwill Goodwill	74419000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5905000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1350000
CY2021Q4	us-gaap	Goodwill Goodwill	81674000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	80137000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1537000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P22M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P21M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3834000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1292000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2338000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1099000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	325000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3762000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	231000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3531000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2835000
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	912000
CY2021	us-gaap	Lease Cost LeaseCost	4380000
CY2022	us-gaap	Lease Cost LeaseCost	3729000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	2173000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2781000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2776000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2710000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3163000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2988000
CY2020	us-gaap	Impairment Lessor Asset Under Operating Lease ImpairmentLessorAssetUnderOperatingLease	0
CY2021	us-gaap	Impairment Lessor Asset Under Operating Lease ImpairmentLessorAssetUnderOperatingLease	0
CY2022	us-gaap	Impairment Lessor Asset Under Operating Lease ImpairmentLessorAssetUnderOperatingLease	2365000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22802000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16975000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	28199000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22802000
CY2021	iclk	Contract With Customer Liability Additions To Deferred Revenue ContractWithCustomerLiabilityAdditionsToDeferredRevenue	135292000
CY2022	iclk	Contract With Customer Liability Additions To Deferred Revenue ContractWithCustomerLiabilityAdditionsToDeferredRevenue	72300000
CY2021	iclk	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	141156000
CY2022	iclk	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	77887000
CY2021	iclk	Contract With Customer Liability Exchange Differences ContractWithCustomerLiabilityExchangeDifferences	-467000
CY2022	iclk	Contract With Customer Liability Exchange Differences ContractWithCustomerLiabilityExchangeDifferences	240000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22802000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16975000
CY2021Q4	iclk	Accrued Rebates Current AccruedRebatesCurrent	733000
CY2022Q4	iclk	Accrued Rebates Current AccruedRebatesCurrent	677000
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	5014000
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	8597000
CY2021Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	418000
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	822000
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	10548000
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	10567000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5076000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4048000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1326000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1257000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	4507000
CY2022Q4	iclk	Consideration Payable Current ConsiderationPayableCurrent	3458000
CY2021Q4	iclk	Advance From Former Non Controlling Interest Shareholder Current AdvanceFromFormerNonControllingInterestShareholderCurrent	475000
CY2022Q4	iclk	Advance From Former Non Controlling Interest Shareholder Current AdvanceFromFormerNonControllingInterestShareholderCurrent	500000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1638000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	613000
CY2021Q4	iclk	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	29735000
CY2022Q4	iclk	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	30539000
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	459000
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	368000
CY2022Q4	iclk	Consideration Payable Non Current ConsiderationPayableNonCurrent	1703000
CY2021Q4	iclk	Accrued Liabilities And Other Liabilities Non Current AccruedLiabilitiesAndOtherLiabilitiesNonCurrent	459000
CY2022Q4	iclk	Accrued Liabilities And Other Liabilities Non Current AccruedLiabilitiesAndOtherLiabilitiesNonCurrent	2071000
CY2022Q4	iclk	Advance From Former Non Controlling Interest AdvanceFromFormerNonControllingInterest	500000
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	75530000
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	44283000
CY2021Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	213289000
CY2022Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	165288000
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	75530000
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	44283000
CY2022Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	97420000
CY2021Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	115338000
CY2021Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0464
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0448
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	0
CY2019Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	49008000
CY2020	iclk	Fair Value Loss Gain On Convertible Notes FairValueLossGainOnConvertibleNotes	4433000
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	19184000
CY2020	iclk	Proceeds From Convertible Notes Upon Exercise Of Call Option ProceedsFromConvertibleNotesUponExerciseOfCallOption	11466000
CY2020	iclk	Conversion Of Convertible Note ConversionOfConvertibleNote	-68895000
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	15196000
CY2019	iclk	Convertible Notes Transaction Expenses ConvertibleNotesTransactionExpenses	4556000
CY2020	iclk	Convertible Notes Transaction Expenses ConvertibleNotesTransactionExpenses	44000
CY2020Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50550000
CY2020Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1365407
CY2020Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	68895000
CY2020	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableToVestWeightedAverageGrantDateFairValue	14.50
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M2D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5213000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	667867
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.16
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M7D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1807000
CY2020	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodGross	235765
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.75
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	432102
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.56
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M10D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4578000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	430569
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.10
CY2020	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue	14.51
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y1M2D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5215000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	431245
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.13
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	432102
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.56
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M10D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4578000
CY2021	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodGross	117788
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.61
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	314314
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M21D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1601000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	312876
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.90
CY2021	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue	15.25
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y8M23D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1601000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	314204
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.95
CY2021	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableToVestWeightedAverageGrantDateFairValue	15.23
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M23D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1601000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	314314
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M21D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1601000
CY2022	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodGross	25341
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.69
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14143
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	19.95
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	274830
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.92
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M8D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	273392
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.33
CY2022	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue	15.37
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y8M8D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	17000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	274720
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.39
CY2022	iclk	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableToVestWeightedAverageGrantDateFairValue	15.35
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M8D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17000
CY2020	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	107000
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4000
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4000
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y3M
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Restricted Stock Expense RestrictedStockExpense	6142000
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	11965000
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	3794000
CY2022Q4	iclk	Number Of Common Stock Per Ads NumberOfCommonStockPerAds	5
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3298000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6249000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13499000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3794000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-421000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	622000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-3183000
CY2020	iclk	Forfeiture Of Advances From Customer ForfeitureOfAdvancesFromCustomer	1245000
CY2021	iclk	Forfeiture Of Advances From Customer ForfeitureOfAdvancesFromCustomer	1654000
CY2022	iclk	Forfeiture Of Advances From Customer ForfeitureOfAdvancesFromCustomer	1552000
CY2020	iclk	Government Subsidy Income GovernmentSubsidyIncome	3063000
CY2021	iclk	Government Subsidy Income GovernmentSubsidyIncome	3281000
CY2022	iclk	Government Subsidy Income GovernmentSubsidyIncome	4458000
CY2020	iclk	Adr Reimbursement From Depositary Bank ADRReimbursementFromDepositaryBank	251000
CY2021	iclk	Adr Reimbursement From Depositary Bank ADRReimbursementFromDepositaryBank	410000
CY2022	iclk	Adr Reimbursement From Depositary Bank ADRReimbursementFromDepositaryBank	-169000
CY2020	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	1404000
CY2021	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	-316000
CY2022	iclk	Fair Value Gains Losses On Short Term Investments FairValueGainsLossesOnShortTermInvestments	-2368000
CY2021	iclk	Other Long Term Investments Accumulated Impairment OtherLongTermInvestmentsAccumulatedImpairment	-4038000
CY2022	iclk	Other Long Term Investments Accumulated Impairment OtherLongTermInvestmentsAccumulatedImpairment	-10805000
CY2020	iclk	Fair Value Change In Contingent Consideration Payable FairValueChangeInContingentConsiderationPayable	-81000
CY2021	iclk	Fair Value Change In Contingent Consideration Payable FairValueChangeInContingentConsiderationPayable	418000
CY2022	iclk	Fair Value Change In Contingent Consideration Payable FairValueChangeInContingentConsiderationPayable	-8396000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	391000
CY2022	iclk	Underpaid Tax Claw Back Period UnderpaidTaxClawBackPeriod	P5Y
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	172000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-254000
CY2020	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	5852000
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	2203000
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-19165000
CY2022	iclk	Percentage Of Vat Super Credit Subsidy From Prc Government PercentageOfVATSuperCreditSubsidyFromPRCGovernment	0.10
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2784000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3445000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	375000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1151000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-905000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11557000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1633000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2540000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11182000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4410000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9438000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	931000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	720000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	254000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4410000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9438000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1185000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	720000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	12993000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	158000
CY2021Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	356000
CY2022Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	1140000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	29000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	28000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13378000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1326000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	47071000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	47071000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5923000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4365000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4410000
CY2020	iclk	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	1144000
CY2021	iclk	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2768000
CY2022	iclk	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	6105000
CY2020	iclk	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	2702000
CY2021	iclk	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	2723000
CY2022	iclk	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	1077000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4365000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4410000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9438000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3291000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3488000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-53491000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4513000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1746000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	7759000
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	627000
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	348000
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	249000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3202000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4783000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	29167000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1558000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	44000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5028000
CY2020	iclk	Income Tax Reconciliation Outside Basis Differences IncomeTaxReconciliationOutsideBasisDifferences	-400000
CY2021	iclk	Income Tax Reconciliation Outside Basis Differences IncomeTaxReconciliationOutsideBasisDifferences	-186000
CY2022	iclk	Income Tax Reconciliation Outside Basis Differences IncomeTaxReconciliationOutsideBasisDifferences	783000
CY2020	iclk	Income Tax Reconciliation Additional Deduction Of Research And Development Expenses IncomeTaxReconciliationAdditionalDeductionOfResearchAndDevelopmentExpenses	-270000
CY2021	iclk	Income Tax Reconciliation Additional Deduction Of Research And Development Expenses IncomeTaxReconciliationAdditionalDeductionOfResearchAndDevelopmentExpenses	-125000
CY2022	iclk	Income Tax Reconciliation Additional Deduction Of Research And Development Expenses IncomeTaxReconciliationAdditionalDeductionOfResearchAndDevelopmentExpenses	-465000
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	64000
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	114000
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	286000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1633000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2540000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11182000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12618000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-13631000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-200875000
CY2020	iclk	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-12618000
CY2021	iclk	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-13631000
CY2022	iclk	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-200875000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39368436
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48187235
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50420225
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.98
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.98
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181482000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	218549000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	173212000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254745000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169080000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1931000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	241000
CY2021Q4	iclk	Contracted But Not Provided For Leasehold Improvements ContractedButNotProvidedForLeaseholdImprovements	0
CY2022Q4	iclk	Contracted But Not Provided For Leasehold Improvements ContractedButNotProvidedForLeaseholdImprovements	0
CY2022	iclk	Appropriation Of Net Income To Statutory Reserve Required Percentage AppropriationOfNetIncomeToStatutoryReserveRequiredPercentage	0.10
CY2022	iclk	Reserve Level Threshold For Mandatory Transfer Percentage ReserveLevelThresholdForMandatoryTransferPercentage	0.50
CY2021Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	69749000
CY2022Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	32239000
CY2022	iclk	Minimum Percentage Of Restricted Net Assets Of Consolidated And Unconsolidated Subsidiaries To Consolidated Net Assets To File Condensed Financial Information MinimumPercentageOfRestrictedNetAssetsOfConsolidatedAndUnconsolidatedSubsidiariesToConsolidatedNetAssetsToFileCondensedFinancialInformation	0.25

Files In Submission

Name	View Source	Status
iclk-20221231_def.xml	Edgar Link	unprocessable
iclk-20221231_cal.xml	Edgar Link	unprocessable
0001104659-23-059102-index-headers.html	Edgar Link	pending
0001104659-23-059102-index.html	Edgar Link	pending
0001104659-23-059102.txt	Edgar Link	pending
0001104659-23-059102-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iclk-20221231.xsd	Edgar Link	pending
iclk-20221231x20f.htm	Edgar Link	pending
iclk-20221231x20f006.jpg	Edgar Link	pending
iclk-20221231x20f009.jpg	Edgar Link	pending
iclk-20221231x20f010.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
iclk-20221231x20f011.jpg	Edgar Link	pending
iclk-20221231x20f012.jpg	Edgar Link	pending
iclk-20221231x20f013.jpg	Edgar Link	pending
iclk-20221231x20f014.jpg	Edgar Link	pending
iclk-20221231xex12d1.htm	Edgar Link	pending
iclk-20221231xex12d2.htm	Edgar Link	pending
iclk-20221231xex13d1.htm	Edgar Link	pending
iclk-20221231xex13d2.htm	Edgar Link	pending
iclk-20221231xex15d1.htm	Edgar Link	pending
iclk-20221231xex15d1001.jpg	Edgar Link	pending
iclk-20221231xex15d1002.jpg	Edgar Link	pending
iclk-20221231xex15d2.htm	Edgar Link	pending
iclk-20221231xex15d2001.jpg	Edgar Link	pending
iclk-20221231xex15d3.htm	Edgar Link	pending
iclk-20221231xex8d1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
iclk-20221231_lab.xml	Edgar Link	unprocessable
iclk-20221231_pre.xml	Edgar Link	unprocessable
iclk-20221231x20f_htm.xml	Edgar Link	completed
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R153.htm	Edgar Link	pending
R154.htm	Edgar Link	pending
R155.htm	Edgar Link	pending
R156.htm	Edgar Link	pending
R157.htm	Edgar Link	pending
R158.htm	Edgar Link	pending
R159.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R160.htm	Edgar Link	pending
R161.htm	Edgar Link	pending
R162.htm	Edgar Link	pending
R163.htm	Edgar Link	pending
R164.htm	Edgar Link	pending
R165.htm	Edgar Link	pending
R166.htm	Edgar Link	pending
R167.htm	Edgar Link	pending
R168.htm	Edgar Link	pending
R169.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R170.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICLK
iClick Interactive Asia Group Ltd Stock $iclk

2022 Q4 Form 20-F Financial Statement

#000110465923059102 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICLK iClick Interactive Asia Group Ltd Stock $iclk

2022 Q4 Form 20-F Financial Statement

#000110465923059102 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICLK
iClick Interactive Asia Group Ltd Stock $iclk